Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 28 studies | 35% ± 14% | |
| endothelial cell of lymphatic vessel | 19 studies | 34% ± 10% | |
| endothelial cell | 10 studies | 22% ± 6% | |
| connective tissue cell | 5 studies | 30% ± 4% | |
| myofibroblast cell | 5 studies | 26% ± 4% | |
| capillary endothelial cell | 5 studies | 19% ± 2% | |
| vein endothelial cell | 5 studies | 20% ± 3% | |
| adventitial cell | 4 studies | 45% ± 4% | |
| mesothelial cell | 4 studies | 29% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| adipose | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 96% | 8187.49 | 629 / 653 | 82% | 3.21 | 494 / 605 |
| adrenal gland | 99% | 11072.29 | 256 / 258 | 75% | 6.30 | 173 / 230 |
| breast | 99% | 13129.63 | 456 / 459 | 71% | 3.96 | 798 / 1118 |
| prostate | 77% | 3859.59 | 189 / 245 | 90% | 4.04 | 451 / 502 |
| ovary | 100% | 19940.67 | 180 / 180 | 66% | 3.11 | 284 / 430 |
| lung | 99% | 15738.10 | 575 / 578 | 66% | 4.92 | 760 / 1155 |
| esophagus | 91% | 12166.59 | 1317 / 1445 | 69% | 6.78 | 127 / 183 |
| uterus | 99% | 19506.74 | 169 / 170 | 47% | 1.54 | 215 / 459 |
| intestine | 93% | 9496.76 | 903 / 966 | 51% | 2.88 | 267 / 527 |
| stomach | 73% | 4955.87 | 262 / 359 | 64% | 6.04 | 183 / 286 |
| bladder | 95% | 9820.71 | 20 / 21 | 41% | 1.98 | 206 / 504 |
| brain | 24% | 1382.69 | 638 / 2642 | 97% | 4.90 | 682 / 705 |
| skin | 78% | 5888.57 | 1409 / 1809 | 42% | 1.69 | 200 / 472 |
| kidney | 43% | 1738.01 | 38 / 89 | 70% | 3.04 | 627 / 901 |
| adipose | 100% | 19628.09 | 1198 / 1204 | 0% | 0 | 0 / 0 |
| heart | 98% | 13242.05 | 847 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 98% | 8896.44 | 1309 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 93% | 4078.00 | 223 / 241 | 0% | 0 | 0 / 0 |
| pancreas | 3% | 74.05 | 9 / 328 | 87% | 5.15 | 154 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 56% | 1.70 | 25 / 45 |
| liver | 8% | 247.83 | 18 / 226 | 43% | 1.41 | 176 / 406 |
| muscle | 46% | 1944.93 | 367 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 34% | 0.63 | 27 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 28% | 0.51 | 8 / 29 |
| peripheral blood | 0% | 2.31 | 1 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007160 | Biological process | cell-matrix adhesion |
| GO_0031175 | Biological process | neuron projection development |
| GO_0007155 | Biological process | cell adhesion |
| GO_0006631 | Biological process | fatty acid metabolic process |
| GO_1900748 | Biological process | positive regulation of vascular endothelial growth factor signaling pathway |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_1905935 | Biological process | positive regulation of cell fate determination |
| GO_0045595 | Biological process | regulation of cell differentiation |
| GO_0030334 | Biological process | regulation of cell migration |
| GO_0006641 | Biological process | triglyceride metabolic process |
| GO_1904028 | Biological process | positive regulation of collagen fibril organization |
| GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
| GO_0008284 | Biological process | positive regulation of cell population proliferation |
| GO_0048251 | Biological process | elastic fiber assembly |
| GO_0030199 | Biological process | collagen fibril organization |
| GO_0030155 | Biological process | regulation of cell adhesion |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0032963 | Biological process | collagen metabolic process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_0031012 | Cellular component | extracellular matrix |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0090733 | Cellular component | tenascin complex |
| GO_0008201 | Molecular function | heparin binding |
| GO_0005201 | Molecular function | extracellular matrix structural constituent |
| GO_0005178 | Molecular function | integrin binding |
| GO_0098633 | Molecular function | collagen fibril binding |
| GO_0005518 | Molecular function | collagen binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | TNXB |
| Protein name | Tenascin-X Tenascin-X (TN-X) (Hexabrachion-like protein) Tenascin XB Tenascin XB (Tenascin-X) TNXB protein |
| Synonyms | TNXB2 XB TNX HXBL TNXB1 |
| Description | FUNCTION: Appears to mediate interactions between cells and the extracellular matrix. Substrate-adhesion molecule that appears to inhibit cell migration. Accelerates collagen fibril formation. May play a role in supporting the growth of epithelial tumors. . |
| Accessions | ENST00000437547.5 P22105 ENST00000424713.5 A0A140TA33 ENST00000417283.5 C9J7W4 ENST00000548649.1 ENST00000448391.5 ENST00000451159.1 A0A140T9L7 ENST00000550539.2 ENST00000546684.2 ENST00000383159.6 ENST00000440248.5 ENST00000442721.1 A0A140TA41 ENST00000647633.1 A0A140T956 A0A140T8Y3 A0A3B3ISX9 ENST00000424226.1 Q6IPK3 A0A140T902 A0A140T8Z8 ENST00000550212.1 ENST00000479795.1 ENST00000424718.5 ENST00000375244.7 [P22105-3] ENST00000427181.5 A0A140T9C0 A0A140TA52 ENST00000451343.4 [P22105-2] ENST00000433037.1 A0A140T923 A0A1B0GX77 ENST00000549232.1 ENST00000412618.5 ENST00000644971.2 [P22105-3] |
